Diversification is a tried-and-true strategy when investing in stocks. Drug maker Sorrento Therapeutics (SRNE) is applying the same thought process in its battle against the coronavirus. The ...

Can you feel the ground moving beneath your feet? Shares of Sorrento Therapeutics (SRNE) skyrocketed 85% today after the small drug maker was made an offer it could, apparently, refuse. The biotech ...

Shares of biopharma stock Sorrento Therapeutics (US:SRNE) finished the week with a 23.7% gain as shares gapped 13% higher on Friday on news that its Scilex subsidiary had completed the long awaited ...

Sorrento Therapeutics Inc (NASDAQ:SRNE) shares are rising on Wednesday after the U.S. Bankruptcy Court granted interim approval of the company's $75 million debtor-in-possession financing. What To ...

Sorrento Therapeutics Inc (NASDAQ:SRNE) shares are getting cut in half Monday morning after the company filed for Chapter 11 bankruptcy. What Happened: Sorrento and its subsidiary, Scintilla ...

As of February 9, 2023, the average one-year price target for Sorrento Therapeutics is $7.82. The forecasts range from a low of $5.05 to a high of $13.65. The average price target represents an ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.